oral chemotherapy drug in clinical trials

CRUK, NIHR and Athenex trial innovative oral chemotherapy 

The experimental oral chemotherapy drug Oraxol is moving into early phase clinical trials.  This is as part of a new partnership between Athenex, Cancer Research...
FDA breakthrough therapy designation for crizanlizumab

FDA breakthrough therapy designation for crizanlizumab

Novartis announces that the FDA has granted breakthrough therapy designation for crizanlizumab for the prevention of VOCs in patients with sickle cell disease (SCD). The...
Amryt announces the results of an unblinded interim efficacy analysis on its pivotal Phase III EASE trial for AP101 for EB.

Amryt announces trial interim efficacy analysis results for EB treatment

Amryt has announced the results of an unblinded interim efficacy analysis on its pivotal Phase III EASE trial for AP101 as a potential treatment...
Janssen have completed an EMA application for Stelara

Janssen submit EMA application for Stelara ® in ulcerative colitis

Janssen have completed an EMA application for Stelara ® for a form of inflammatory bowel disease (IBD) - ulcerative colitis  The Janssen Pharmaceutical Companies of Johnson...

Bristol-Myers Squibb & Celgene Corporation announce a definitive merger agreement

Bristol-Myers Squibb Company and Celgene Corporation have announced that they have entered into a definitive merger agreement under which Bristol-Myers Squibb will acquire Celgene...
Microscope and equipment showing new Vaccines Manufacturing Innovation Centre

First diagnostic saliva test for malaria to launch

ERADA Technology Alliance Ltd (ERADA) has announced the imminent launch of a ground-breaking diagnostic saliva test for malaria. The saliva-based diagnostic tool, to be marketed...

Lynparza is approved by FDA for advanced ovarian cancer

AstraZeneca and MSD announce Lynparza is approved by FDA for adult patients with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer. AstraZeneca and MSD...
Dengvaxia®, Sanofi's dengue vaccine.

Dengvaxia ® vaccine approved for dengue prevention in Europe

The European Commission has granted marketing authorisation for Dengvaxia ®, Sanofi's dengue vaccine. The marketing authorisation follows the October 18, 2018, recommendation by the European...
Amryt announces the results of an unblinded interim efficacy analysis on its pivotal Phase III EASE trial for AP101 for EB.

Almirall releases results of onychomycosis phase III trial of P-3058

Almirall announces that the pivotal study for P-3058 has met the primary endpoint in an onychomycosis phase III trial.  Almirall, S.A (ALM) has announced that...
Any closure at Ashton-Under-Lyne facility would affect approximately 140 Recipharm employees.

Recipharm explores ending operations in Ashton-under-Lyne facility

Recipharm is to initiate a process to explore the discontinuance of operations at its solid dose manufacturing facility in Ashton-under-Lyne, UK. The decision to initiate...

Latest articles

Prostate cancer treatment Erleada

Janssen’s prostate cancer treatment Erleada receives EC licence 

Johnson & Johnson announce that the European Commission (EC) has licensed prostate cancer treatment Erleada for non-metastatic castration-resistant prostate cancer (nmCRPC) The licence is based on...
transforming engagement for precision medicine with the cloud

The role of the cloud in transforming engagement for precision medicine

What role does technology play in transforming engagement to deliver precision information for precision medicine? Malia Lewin explores. Oncology is both the largest and fastest-growing therapeutic...
Sue Bennett has a liver transplant using a procedure to make livers viable for transplant

NICE: Procedure could make more livers viable for transplant

A procedure assessed by NICE has been hailed as an “exciting development” in increasing the number of livers viable for transplant.  A perfusion machine can...